Contributor: Fuel drug development, not Big Pharma’s profits
RSS SUMMARY · AGGREGATED FROM LAT
More than 200 drugs in the pipeline for ALS are stuck in a system that favors big, slow-moving pharmaceutical companies.
More than 200 drugs in the pipeline for ALS are stuck in a system that favors big, slow-moving pharmaceutical companies.
More than 200 drugs in the pipeline for ALS are stuck in a system that favors big, slow-moving pharmaceutical companies.
Continue Reading
The full story continues on Los Angeles Times.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
LAT
Sports
How ‘Welcome to Wrexham’ kickstarted a $250-million economic boom for Welsh town
LAT·3h ago·3 min read
Sports
Prep talk: Villa Park pitching duo will be tough to stop in Division 2 baseball playoffs
LAT·3h ago·3 min read
Sports
Fútbol fashion at its extreme, in the best possible way
LAT·4h ago·3 min read
Science
Footage shows Central Valley dairy workers kicking young calves, pulling them with pliers
LAT·4h ago·3 min read
Related
On this beat
Science
Star Catcher just raised $65 million to build the world’s first power grid in space — with lasers
SPACE·1h ago·3 min read
Science
Uterus transplants can provide a path to pregnancy and parenthood
SCIENCE NEWS·52m ago·3 min read
Science
Scientists reversed biological age in older adults with a 4-week diet change
SD·1h ago·3 min read
Science
A hidden wildfire pollutant causes thousands of excess deaths per year, satellite data shows
SPACE·2h ago·3 min read